Last updated on February 2018

Short Duration Treatment of Non-severe Community Acquired Pneumonia


Brief description of study

To investigate the non inferiority of a short lasting antibiotic treatment (3 days) when compared to a long lasting antibiotic treatment (8 days), at Day 15 after the beginning of treatment in terms of clinical efficacy, in adults admitted to emergency services for a non severe Community Acquired Pneumonia (PAC), who responded well to 3 days of beta-lactamin treatment (3GC or A/AC).

Clinical Study Identifier: NCT01963442

Find a site near you

Start Over

Foch Hospital

Suresnes, France
2.11miles
  Connect »

CHU Ambroise Par

Boulogne-Billancourt, France
4.35miles
  Connect »

CH Versailles

Le Chesnay, France
4.49miles
  Connect »

CH Argenteuil

Argenteuil, France
5.46miles
  Connect »

CH Beaujon

Clichy, France
6.07miles
  Connect »

CHU Bichat

Paris, France
8.02miles
  Connect »

CH Saint Denis

Saint Denis, France
8.99miles
  Connect »

CH Bic tre

Le Kremlin Bicètre, France
9.6miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.